Compare CW & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CW | RMD |
|---|---|---|
| Founded | 1929 | 1989 |
| Country | United States | United States |
| Employees | N/A | 10600 |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.0B | 29.4B |
| IPO Year | 1994 | N/A |
| Metric | CW | RMD |
|---|---|---|
| Price | $721.17 | $187.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $616.83 | $292.56 |
| AVG Volume (30 Days) | 222.8K | ★ 1.3M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | 0.14% | ★ 1.13% |
| EPS Growth | ★ 21.99 | N/A |
| EPS | ★ 3.46 | N/A |
| Revenue | ★ $2,391,336,000.00 | N/A |
| Revenue This Year | $10.42 | $10.60 |
| Revenue Next Year | $7.87 | $7.41 |
| P/E Ratio | $215.53 | ★ $25.61 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $443.00 | $190.51 |
| 52 Week High | $760.72 | $293.81 |
| Indicator | CW | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.94 | 25.29 |
| Support Level | $689.96 | N/A |
| Resistance Level | $754.43 | $260.21 |
| Average True Range (ATR) | 22.05 | 5.20 |
| MACD | -0.25 | -0.79 |
| Stochastic Oscillator | 48.18 | 12.93 |
Curtiss-Wright Corporation delivers engineered products and services to commercial, defence, power generation, and other industrial markets. It offers industrial vehicle components, control systems, weapons handling systems, pumps, valves, and other solutions. The company has three reportable segments based on the markets serviced: Naval & Power, which provides coolant pumps, power-dense compact motors, generators, secondary propulsion systems, pumps, pump seals, valves, control rod drive mechanisms, and fastening systems that also generate maximum revenue for the company; its other segments are Aerospace & Industrial and Defense Electronics. Geographically, the company generates its key revenue from the United States of America, followed by the United Kingdom and other countries.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.